Securities Arbitration Lawyers BlogSilver Law Group Investigating Zosano Pharma Corporation (ZSAN)
Silver Law Group is investigating Zosano Pharma Corporation (ZSAN) regarding potential violations of federal securities laws.
If you have losses from investing in Zosano Pharma Corporation (ZSAN), please contact Silver Law Group for a no cost consultation at (800) 975-4345 or by email at ssilver@silverlaw.com.
Zosano Pharma Corporation is a biopharmaceutical company headquartered in California that provides “therapeutics to patients suffering from migraine using its Adhesive Dermally-Applied Microarray technology.” Zosano’s lead product candidate is called Qtrypta, which is a formulation of zolmitriptan to treat migraines.
FDA’s Questions About Qtrypta Cause Stock To Crash
On September 30, 2020, Zosano put out a press release that stated the company had received a discipline review letter (DRL) from the Food and Drug Administration (FDA) related to its New Drug Application (NDA) for Qtrypta.
Zosana press release notified investors that the DRL listed two concerns related to the NDA for Qtrypta. The FDA had questions regarding:
- The unexpected high plasma levels of zolmitripan in five study subjects and how that data would affect Qtrypta’s application.
- Differences in zolmitriptan exposures between test subjects getting different lots of Qtryptra in trials.
Steven Lo, chief executive and president of Zosano, said “We are disappointed in this notification and are in the process of evaluating and addressing FDA’s comments.”
The news caused Zosano’s stock to fall by nearly 57%, causing significant losses for investors.
Recovering Zosano Pharma Corporation (ZSAN) Investment Losses
If you have investment losses with Zosano Pharma Corporation (ZSAN), contact Silver Law Group to discuss options to recover your losses.
Silver Law Group is a nationally-recognized class action law firm representing investors who have been the victims of investment fraud. Our attorneys represent investors in class actions against issuers in state or federal court as well as investors in securities arbitration claims against Wall Street firms for stockbroker misconduct.
Scott Silver, Silver Law Group’s managing partner, is the chairman of the Securities and Financial Fraud Group of the American Association of Justice. Contact us today at ssilver@silverlaw.com or toll free at (800) 975-4345.